Stock RV6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Charles River Laboratories International, Inc. Deutsche Boerse AG

Equities

RV6

US1598641074

Market Closed - Deutsche Boerse AG
Other stock markets
 07:02:17 03/05/2024 BST 		5-day change 1st Jan Change
213.8 EUR -0.28% Intraday chart for Charles River Laboratories International, Inc. +0.56% -0.14%
04-25 FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids CI
04-24 Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission CI

Chart calendar Charles River Laboratories International, Inc.

0fde1ad73c4e3f59.79vNOmDyRjKuJJaPsQ-z4tsMROC5BJdDjG7cs4Xe7GU.h4y0DQSWA33LFuHIgHvDgelvKtDTaaMm-1iZ1vSVh1ystYMOI4Y1eeoS2w~bbe85ee798d929bc9fb292ebbd7948e8

Upcoming events on Charles River Laboratories International, Inc.

08/05/2024 13:00 Annual General Meeting
09/05/2024 12:00 Q1 2024 Earnings Release
09/05/2024 13:30 Q1 2024 Earnings Call
30/07/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
11/02/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Charles River Laboratories International, Inc.

09/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:6181
09/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:5467
09/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:5315
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4703
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4413
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4224
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4191
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4186
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4182
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:3975
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2841
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2840
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2835
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2714
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2630
08/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:2053
08/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:2020
08/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:1453
08/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:1335
07/04/2024 21:30 American Association for Cancer Research Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		2 621
2 614
0.28%		2 924
2 891
1.15%		3 540
3 522
0.52%		3 976
3 915
1.56%		4 129
4 107
0.54%
4 223

EBITDA
Million USD		Released
Forecast
Spread 		604
597
1.28%		701
693
1.26%		879
878
0.22%		991
982
0.87%		1 013
1 017
-0.4%
1 063

EBIT
Million USD		Released
Forecast
Spread 		497
489
1.64%		585
575
1.73%		742
738
0.51%		834
820
1.67%		839
842
-0.35%
877

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		304
284
7.16%		447
394
13.45%		481
449
7.01%		623
568
9.63%		581
513
13.41%
552

Net income
Million USD		Released
Forecast
Spread 		252
240
4.84%		364
296
23%		391
358
9.2%		486
409
18.85%		475
387
22.66%
420

EPS
USD		Released
Forecast
Spread 		5,07
4,85
4.57%		7,20
5,88
22.44%		7,60
6,99
8.67%		9,48
7,97
18.98%		9,22
7,49
23.07%
8,10

Announcement Date11/02/2017/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		905
888
1.89%		914
909
0.58%		973
995
-2.22%		989
970
1.93%		1 100
1 035
6.26%		1 029
986
4.39%		1 060
1 054
0.59%		1 027
1 000
2.61%		1 013
991
2.24%
993


1 042


1 075


1 113


1 069

EBITDA
Million USD		Released
Forecast
Spread 		227
227
-0.22%		233
233
0.02%		250
247
1.36%		240
238
1.14%		267
260
2.72%		260
252
3.03%		260
258
0.62%		255
241
5.8%		239
242
-1.38%
222


258


283


300


245

EBIT
Million USD		Released
Forecast
Spread 		189
184
2.52%		196
194
1.26%		212
208
1.97%		201
197
2.26%		225
213
5.33%		218
209
3.98%		216
213
1.41%		211
194
8.51%		194
196
-1%
178


212


236


251


203

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		164
135
21.45%		111
149
-25.64%		144
142
1.83%		123
128
-3.67%		245
155
57.85%		131
150
-12.47%		129
143
-10.32%		113
120
-6.11%		209
120
74.62%
96,3


130


157


173


145

Net income
Million USD		Released
Forecast
Spread 		138
109
26.5%		93,0
109
-14.63%		109
110
-0.34%		96,5
98,4
-1.95%		187
109
71.19%		103
102
0.7%		97,0
105
-7.26%		87,4
88,9
-1.74%		187
92,4
102.53%
71,2


99,9


120


132


103

EPS
USD		Released
Forecast
Spread 		2,67
2,03
31.32%		1,81
2,07
-12.39%		2,13
2,13
-0.04%		1,88
1,84
2.12%		3,65
2,14
70.86%		2,01
1,99
0.87%		1,89
2,04
-7.23%		1,69
1,68
0.51%		3,62
1,78
103.94%
1,35


1,92


2,31


2,52


1,96

Announcement Date16/02/2204/05/2203/08/2202/11/2222/02/2311/05/2309/08/2308/11/2314/02/24-----

Upcoming sector events for Charles River Laboratories International, Inc.

06/05/2024 FORTREA HOLDINGS INC.: Q1 2024 Earnings Release
06/05/2024 VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 PHARVARIS N.V.: Q1 2024 Earnings Release (Projected)
06/05/2024 IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 NOVAVAX, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024 06:00 VALNEVA: Q1 2024 Earnings Release
07/05/2024 12:00 IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
More events

Past sector events for Charles River Laboratories International, Inc.

02/05/2024 21:10 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release
02/05/2024 21:05 VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
02/05/2024 21:05 RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release
02/05/2024 21:01 GALAPAGOS NV: Q1 2024 Earnings Release
02/05/2024 13:00 ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
02/05/2024 12:05 SHATTUCK LABS, INC.: Q1 2024 Earnings Release
02/05/2024 12:00 BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release
02/05/2024 12:00 KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release
02/05/2024 12:00 IQVIA HOLDINGS INC.: Q1 2024 Earnings Release
02/05/2024 11:30 MODERNA, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. RV6 Stock
  5. Calendar Charles River Laboratories International, Inc.